News

Criteo's Strategic Move to Luxembourg: What You Need to Know

Criteo's Strategic Move to Luxembourg: What You Need to Know

Criteo's Strategic Shift to Luxembourg

Criteo S.A. (NASDAQ: CRTO), a pioneering platform in the commerce ecosystem, has announced an important decision regarding its corporate structure. This initiative focuses on transferring its legal domicile from France to Luxembourg, a step designed to streamline operations and enhance shareholder value.

Board Approval and Future Plans

The company’s Board of Directors has recently given the green light to this strategic move after receiving a favorable opinion from the works council. This transition, referred to as the Conversion, will replace the current American Depositary Shares (ADSs) structure with ordinary shares listed directly on Nasdaq, marking a significant evolution in Criteo’s corporate framework.

The Importance of This Move

Frederik van der Kooi, Chairman of the Board, expressed his enthusiasm, stating that this decision is poised to unlock substantial shareholder value. By simplifying the corporate structure, Criteo aims to enhance its capital management flexibility, aligning its market presence with its long-term strategic ambitions. This move also demonstrates Criteo's commitment to its workforce in France and its integral role in the technology and AI landscapes.

Shareholder Meeting to Approve Changes

To solidify this change, Criteo plans to hold a general meeting for shareholders on February 27, 2026, where the proposed Conversion and other related matters will be voted on. The meeting is set to take place at the Company’s registered office, allowing ordinary shareholders to voice their opinions and make decisions regarding this significant initiative.

Registration and Voting Process

The Board has established February 25, 2026, as the record date for voting eligibility. This means that those who hold ordinary shares on that date can participate in the decision-making process. For those holding ADSs, they will receive instructions through their brokers on how to vote their underlying shares, ensuring that all stakeholders have a voice in this transition.

Timeline for the Conversion

The completion of the Conversion is tentatively scheduled for the third quarter of 2026, contingent on shareholder approval and other customary conditions being met. Criteo is already preparing for a further potential move from Luxembourg to the United States in the future, should the Board find it beneficial for the company and its shareholders, post comprehensive consultations with the works council.

A Closer Look at Criteo's Operations

Criteo is renowned for connecting brands, agencies, retailers, and media owners through its advanced AI-driven advertising platform. Accessing an impressive $1 trillion in annual commerce sales, Criteo provides businesses with tools and insights necessary for achieving performance and growth. Collaborating with thousands of clients globally, Criteo continues to enhance the digital commerce ecosystem.

About Criteo

Criteo (NASDAQ: CRTO) stands out in the global commerce arena, offering innovative advertising solutions that operate on vast data about shopper behavior. This unique access allows for tailored advertising strategies that resonate with consumers on a personal level, driving engagement and satisfaction.

Frequently Asked Questions

What is Criteo planning regarding its legal domicile?

Criteo plans to transfer its legal domicile from France to Luxembourg to better streamline its corporate structure and increase shareholder value.

When will shareholders be able to vote on this transition?

Shareholders can vote on the proposed changes during a general meeting scheduled for February 27, 2026.

What is the expected timeline for the completion of the Conversion?

The Conversion is expected to be completed by the third quarter of 2026, pending shareholder approvals and necessary conditions.

How does Criteo connect with its customers?

Criteo utilizes its AI-driven platform to analyze over $1 trillion in annual commerce sales, facilitating targeted advertising that enhances customer engagement.

Will Criteo seek to redomicile to the U.S. after the Luxembourg move?

Yes, if deemed beneficial, Criteo intends to pursue a subsequent redomiciliation to the United States following the completion of the Luxembourg transition.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 4

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 3

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 3

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Updated Category News Views 3

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 3

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 2

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading

Top 5 Most Recently Viewed Articles

Breakthrough Gene Therapy Study Offers Hope for Danon Disease

Updated Category News Views 110

Revolutionary Advances in Gene Therapy for Danon Disease Recent findings from groundbreaking research at Children's Hospital of Philadelphia reveal a promising new approach in tackling Danon disease, a complex genetic disorder predominantly affecting young males. The study not only highlights the potential of gene therapy—specifically a novel treatment known as...

Continue Reading
Biohaven Doses First Patient with Innovative BHV-8100

Updated Category News Views 4

Biohaven Breaks New Ground with BHV-8100 There’s a fresh buzz in the biopharma world as Biohaven Ltd. kicks off first-in-human dosing for their novel drug, BHV-8100. This is no small feat, and it could potentially shake up the landscape of treatments for systemic and central nervous system disorders. You know there’s weight behind a drug when it’s aiming for those...

Continue Reading
Nasdaq Sets Date for 2026 Investor Day Event

Updated Category News Views 372

Exciting Announcement from Nasdaq Nasdaq recently shared significant news regarding its upcoming 2026 Investor Day. Scheduled for the morning of February 25, 2026, this highly anticipated event will take place at the Nasdaq Global Headquarters in Times Square. This annual gathering is essential for investors as it provides insights into the company's strategic direction...

Continue Reading
Acreage Holdings Restructures Debt Agreement for Growth

Updated Category News Views 89

Acreage Holdings Restructures Debt Agreement with Canopy USA Acreage Holdings (OTC: ACRGF), Inc. is a diversified cannabis company, recently announced a strategic amendment to its debt agreement with Canopy USA, LLC, which impacts the payment terms of its outstanding obligations. This pivotal financial maneuver came into effect recently and is a reflection of the...

Continue Reading
Chlorella Market Projected Growth and Nutritional Benefits

Updated Category News Views 233

Understanding the Growth of the Chlorella Market Chlorella occupies an important place in the sphere of superfoods. This vibrant freshwater alga, famous for its rich nutritional profile, plays a vital role in the health and wellness trend that is sweeping across the globe. It is known for its presence in pills, powders, capsules, and liquid extracts, marking its...

Continue Reading